MINNEAPOLIS, Jan. 26 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of physiological monitoring solutions, made history today by announcing the first Continua(TM) Certified product. The Nonin 2500 PalmSAT(R) handheld pulse oximeter with USB is the first product to be certified to meet the Continua design guidelines. With the award-winning Bluetooth(R) Onyx(R) II, Model 9560 currently in the process of certification, Nonin Medical plans to offer Continua compliant tools across its product lines.
"I'm proud to welcome the first Continua Certified product to the global marketplace from industry leader and Continua Promoter member Nonin Medical, Inc.," said David Whitlinger, Continua Health Alliance President. "Nonin Medical's engineers have worked diligently with other telehealth leaders in the alliance to produce the Continua Version One Guidelines, with the goal of building Continua's vision for interoperable and personal healthcare."
Information exchange and interoperability promise to deliver enormous benefits to healthcare systems and telemedicine programs -- patients will have better information about their health status and clinicians will have the ability to monitor vital signs with much greater ease. "Based on our experience, we believe patients will appreciate these broadened options to help them manage their health, and the healthcare system will save money having an entire ecosystem of products that work together," said Dr. Joseph Kvedar, Founder and Director of the Center for Connected Health, Boston. "In today's global economy, that's a win-win."
Nonin has been a key contributor in the architecture of interoperable standards, including ISO/IEEE 11073, USB Personal Healthcare Device Class (PHDC) and Bluetooth(R) Health Device Profile (HDP) -- all part of the Continua Alliance Certification requirements. Dedicated to developing cross-industry standards to reduce the cost of healthcare, Nonin is working with a wide array of Continua partners to achieve this goal. "This kind of dedication and foresight from companies such as Nonin Medical ensure this is only the beginning of Continua's personal telehealth ecosystem," said David Whitlinger. "As we usher in 2009, Continua will continue to certify a variety of our membership's products, thereby furthering our mission of truly personal health and wellness."
Nonin's physiological monitoring products for telemedicine are the prevailing gold standard for vital sign assessment of a wide range of chronic disease conditions, such as COPD, CHF and asthma. Trusted by clinicians worldwide, Nonin's products touch millions of individuals daily. Making its vision of an interoperable personal health ecosystem a reality, Nonin continues to actively invest and develop innovative technologies and education tools for patient empowerment, wellness advocates, healthcare providers, and manufacturers.
About Nonin Medical, Inc. -- http://www.nonin.com
Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 90 OEM partners worldwide. Nonin's industry-leading capabilities in signal processing and sensor design, plus its on-going integration of features not available in competitive products, are the foundation of its leadership in innovation.
About the Continua Health Alliance -- http://www.continuaalliance.org
The Continua Health Alliance is a non-profit, open industry coalition of the finest healthcare and technology companies joining together in collaboration to improve the quality of personal healthcare. With more than 170 member companies around the world, Continua is dedicated to establishing a system of interoperable personal health solutions with the knowledge that extending those solutions into the home fosters independence, empowers individuals and provides the opportunity for truly personalized health and wellness management.
|SOURCE Nonin Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved